In theory, this suggests that thered be fewer ups and downs over the dosing period and as a result, things like total daily dose and insulin sensitivity would be likely to remain within a range that would be much easier to manage
Jean, MSN, FNP-C, founded JSJ Aesthetics in 2014
This also leads to a loss of muscle mass, which further reduces metabolic rate
Reward Regulation : It impacts the dopaminergic pathways, reducing the "reward" or pleasure derived from high-calorie foods, making it easier to resist cravings
This commentary summarizes evidence demonstrating beneficial effects of GLP-1 medicines on conditions other than T2D or obesity, including cardiovascular disease (CVD), CKD, MASLD, osteoarthritis (OA), obstructive sleep apnea (OSA), and peripheral artery disease (PAD) (Figure 1A)